Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients

Henrik Sillesen, PERFORM and SPARCL Investigators and Committee

43 Citations (Scopus)
Original languageEnglish
JournalStroke
Volume45
Issue number5
Pages (from-to)1429-1436
ISSN0039-2499
DOIs
Publication statusPublished - May 2014

Keywords

  • cardiovascular diseases
  • HMG-CoA reductase inhibitors
  • lipids
  • stroke

Fingerprint

Dive into the research topics of 'Atherogenic Dyslipidemia and Residual Cardiovascular Risk in Statin-Treated Patients'. Together they form a unique fingerprint.

Cite this